Call For Papers

We invite you to submit high-quality papers in English for review and possible publication in all areas of medicine, psychology, public, occupational and environmental health.

SUBMISSION CHEKCLIST

As part of the submission process, authors are required to check off their submission’s compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.

The submission has not been previously published, nor it has been submitted to another journal for consideration:

The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines.
The manuscript text file is created the AMPPH Article Template and does incorporates both tables and images.
All the images are placed in separate files, in TIFF or EPS file format, and adhere to the PMC reference table. Images included in Microsoft Office Word file formats WILL NOT be accepted.
Tables are filled in APA style

HOW TO SUBMIT

The submission should include:

Cover letter
Main manuscript including: 1) Abstract containing a maximum of 250 words, followed, below it, by up to five keywords or brief phrases to assist in indexing. (MeSH headings, whenever possible. Refer to: www.nlm.nih.gov/mesh/meshhome.html);
Tables according to the APA style
Figures (a minimum resolution of 300 DPI is required).

Please, use for your manuscript the AMPPH Article Template and DO not SUBMIT pdf files.

SUBMIT YOUR PAPER VIA EMAIL TO:

editor@ampphealthjournal-network.org

HOW TO WRITE THE COVER LETTER

All manuscripts submitted to AMPPH, must be accompanied by a letter (cover letter), written by the author for the correspondence (on behalf of all co-authors), declaring that this manuscript is original, is not published, in press, or submitted elsewhere in English or any other language, and is not currently being considered for publication elsewhere. The submitted cover letter should declare that all authors have seen and approved the content of the manuscript and have contributed significantly to the work. Authors should declare the conflict of interest statement (a conflict of interest exists when authors or their institutions have financial or personal relationship with other people or organizations that could inappropriately bias conduct and findings of the study). Authors should declare to have permission to reproduce figures, if appropriate. Authors should deal responsibly and effectively with security issues that might be raised by their papers (see: Statement on Scientific Publication and Security Science 2003;299:1149). Authors should declare if the paper has been previously presented as a conference abstract or published as pre-print. The corresponding author should declare any funding or financial support of the research, and complete affiliation, e-mail, and possibly ORCID, of all the authors. The corresponding author may suggest three potential unbiased reviewers (with their email addresses) who are qualified to review their manuscript. A rebuttal letter must also accompany a revised submission and must address, point by point, issues raised in the review process.

AUTHORS GUIDELINES-pdf

TEXT

Use font, margin and style of the AMPPH template;
do not use the automated features of your application (endnotes, headers, footers, especially for references);
type a single space at the end of each sentence;
avoid using bold characters to emphasise words or sentences within the text;
indicate clearly titles of chapters and subchapters avoiding numbering;
do not use capital letters in the title and text.

Manuscript should be prepared using Microsoft Word for Windows. Do not send the text in PDF. Define acronyms at first mention in the text. Notes to the text, indicated by asterisks or similar symbols, should appear at the bottom of the relevant page. Mathematical terms and formulae, abbreviations, and units of measure should conform to the standards set out in Science 1954;120:1078. Drugs should be referred to by their chemical name; the commercial name should be used only when absolutely unavoidable (capitalizing the first letter of the product name and giving the name of the pharmaceutical firm manufacturing the drug, town and country).

TABLES AND FIGURES

All tables are to be numbered using Arabic numerals.
Tables should always be cited in text in consecutive numerical order.
For each table, please supply a table caption (title) explaining the components of the table.
Identify any previously published material by giving the original source in the form of a reference at the end of the table caption.
Footnotes to tables should be indicated by superscript lower-case letters (or asterisks for significance values and other statistical data) and included beneath the table body.
In the text and legend of the tables, authors must use, in the exact order, the following symbols: *, †, ‡, ¶, **, ††, ‡‡ …
All figures are to be numbered using Arabic numerals.

Figures should always be cited in text in consecutive numerical order.
Figure parts should be denoted by lowercase letters (a, b, c, etc.).
Each figure should have a concise caption describing accurately what the figure depicts. Include the captions in the text file of the manuscript, not in the figure file.
Figure captions begin with the term Figure 1 in bold type, followed by the figure number, also in bold type.
Punctuation is to be included after the number and punctuation has to be placed at the end of the caption.
All the images are placed embedded in the text and in separate files, in JPEG with a high-definition format (at least 300 DPI) , and adhere to the PMC reference table (Image Quality Specifications (nih.gov)
Identify previously published material by giving the original source in the form of a reference citation at the end of the figure caption.
When preparing your figures, size figures to fit in the column width.
If you include figures that have already been published elsewhere, you must obtain permission from the copyright owner(s) for both the print and online format. Please be aware that some publishers do not grant electronic rights for free and that AMPPH will not be able to refund any costs that may have occurred to receive these permissions. In such cases, material from other sources should be used.

ABSTRACT

Abstract should contain a maximum of 250 words, followed below it, by up to five keywords or brief phrases to assist in indexing. (MeSH headings, whenever possible. Refer to: www.nlm.nih.gov/mesh/meshhome.html).

Abbreviations

The first time an uncommon abbreviation appears it should be explained in parenthesis. For writing symbols, quantities and units of measurements refer to the International Systems of Units (SI) and the ISO Standards.

Acknowledgements

Acknowledgments and mention of any grants or other forms of financial support should appear at the end of the paper in the specific section, before the list of references.

References

All references in the text must be indicated by the corresponding Arabic numerals in square brackets, i.e. [1], [2, 3-6] [7, 10, 12], and mentioned at the end of the article in the order in which they are quoted. The Vancouver style of referencing is used in line with the recommendations of the International Committee of Medical Journal Editors: (Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Sample References,2013). Titles of periodicals should be abbreviated in accordance with the Medline abbreviation of the US National Library of Medicine (www.nlm.nih.gov/bsd/aim.html). Online journal articles can be cited using, in addition to the complete citation, the DOI number. Responsibility for the accuracy and completeness of references lies with the author. If the work you need to reference has more than six authors, you should list the first six authors, followed by ‘et al.’. Page numbers should not be abbreviated, but left in full. Where available, both URLs (“Available from”) and “accessed on” (date) for the references must be provided.

Examples for the style to be used for the list of references are given below.

References should be compiled following the examples below.

Standard Journal Article

You CH, Lee KY, Chey RY, Menguy R. Electrogastrographic study of patients with unexplained nausea, bloating and vomiting. Gastroenterology. 1980;79(2):311-314.

Petrie KJ, Muller JT, Schirmbeck F, Donkin L, Broadbent E, Ellis CJ, et al. Effect of providing information about normal test results on patients’ reassurance: randomised controlled trial. Br Med J. 2007;334(7589):352–254.

E- Journal with a DOI

Camiller M, Parkman HP, Shafi MA, et al. Clinical guideline: management of gastroparesis.Am J Gastroenterol. Am J Gastroenterol. 2013 January;108(1):18–38. doi: 10.1038/ajg.2012.373

Journal article: no author

21st century heart solution may have a sting in the tail. BMJ. 2002;325(7537):184.

Journal article: Issue with no volume

Banit DM, Kaufer H, Hartford JM. Intraoperative frozen section analysis in revision total joint arthroplasty. Clin Orthop. 2002;(401):230-238.

Volume with supplement

Geraud G, Spierings EL, Keywood C. Tolerability and safety of frovatriptan with short- and long-term use for treatment of migraine and in comparison with sumatriptan. Headache. 2002;42 Suppl 2:S93-99.

Issue with supplement

Glauser TA. Integrating clinical trial data into clinical practice. Neurology. 2002;58(12 Suppl 7):S6-12.

Documents available on the web:

Goldacre B. Dore – the media’s miracle cure for dyslexia. Bad Science. Weblog [cited 2015 Dec 27]. Available from: http://www.badscience.net/2008/05/dore-the-medias-miracle-cure-for-dyslexia/#more-705 .

Book online/electronic:

Simons NE, Menzies B, Matthews M. A Short Course in Soil and Rock Slope Engineering.
London: Thomas Telford Publishing; 2001. Accessed on 22 June 2016. Available from: http://www.myilibrary.com?ID=93941 .

Standard
British Standards Institution. BS 5950–8:2003. Structural use of steelwork in building: code of practice for fire resistant design. London: BSI; 2003.

Chapter in a Book:

Partridge H, Hallam G. Evidence-based practice and information literacy. In: Lipu S, Williamson K, Lloyd A. (eds.) Exploring methods in information literacy research. Wagga Wagga, Australia: Centre for Information Studies; 2007. p. 149–170.

Conference Proceeding

Wittke M. Design, construction, supervision and long-term behaviour of tunnels in swelling rock. In: Van Cotthem A, Charlier R, Thimus J-F, Tshibangu J-P. (eds.) Eurock 2006: multiphysics coupling and long term behaviour in rock mechanics: Proceedings of the International Symposium of the International Society for Rock Mechanics, EUROCK 2006, 9–12 May 2006, Liège, Belgium. London: Taylor & Francis; 2006. p. 211–216.

Scientific and technical reports

Akutsu T. Total heart replacement device. Bethesda (MD): National Institutes of Health, National Heart and Lung Institute; 1974 Apr. Report No.: NIH-NHLI-69- 2185-4.

Sometimes submitted manuscripts need Editorial improvements that require consultation between the authors and the editorial board. AMPPH has a specialized editorial staff and a scientific committee, to work with authors to generate an article that meets international publication standards.

This may include editing for english, reorganization of the manuscript, or even suggestions on experimental design. Working in an interactive manner will be able to achieve not only a manuscript at international standards but also the exchange of ideas and methods for publishing in other international journals.

The role of the Corresponding Author

Corresponding Author and Group Authorship

The corresponding author will serve on behalf of all co-authors as the primary correspondent with the editorial office during the submission and review process. If the manuscript is accepted, the corresponding author will review an edited typescript and proof and will be identified as the corresponding author in the published article. The corresponding author will be the responsible for the publication process, from the submission to the post-publication stage.

TYPE OF ARTICLES

The following types of contributions will be considered for publication.

Original Article

Description: Articles with new findings and original research results, research methodologies, research materials and interpretations of the authors’ own or of other research results and articles of a similar nature. Word limit: 4,000 words maximum excluding abstract, acknowledgment, references, tables and figure legends. Abstract: 250 words maximum, structured. Keywords: 3-6 keywords. References: 40 maximum. Figure/Tables: 6 maximum.

Review Article

Description: Review (systematic review, rapid systematic review, meta-analysis, mapping review, scoping review) on a specific topic. Word limit: 6,000 words maximum excluding abstract, acknowledgment, references, tables and figure legends. Abstract: 250 words maximum, structured. Keywords:3-6 keywords. References: no limit. Figure/Tables: 6 maximum.

Brief Report

Description: Articles with limited but original data and having the same format as Original Article.
Word limit: 3,000 words maximum excluding abstract, acknowledgment, references, tables and figure legends. Abstract: 250 words maximum, structured. Keywords: 3-6 keywords. References: 15 maximum. Figure/Tables: 2 maximum.

Case Report

Description: Reports on cases of interest in the field of medicine, occupational health and/or environment. Word limit: 3,000 words maximum excluding abstract, acknowledgment, references, tables and figure legends. Abstract: 250 words maximum, structured. Keywords: 3-6 keywords. References: 20 maximum. Figure/Tables: 6 maximum.

Opinion

Description: Short articles conveying authors’ own opinions or comments on various aspects of medicine or public health. Abstract: 250 words maximum, structured. Or can be unstructured if appropriate. Keywords: 3-6 keywords. References: 40 maximum. Figure/Tables: 6 maximum.

Letter to the Editor

Description: Letters to the Editor on material published in the AMPPH are welcome. When appropriate, the Journal may invite replies. Word limit: 800 words maximum excluding references, table and figure legends. Abstract: Not required. Keywords: 3-6 keywords. References: 5 maximum. Figures/Tables: 1 maximum.

Reporting guidelines

Manuscripts should conform to the following reporting guidelines:

Studies of diagnostic accuracy: STARD
Observational studies: STROBE
Microarray experiments: MIAME
Other types of health-related research: Consult the EQUATOR web site for appropriate reporting guidelines.

Clinical trials must be reported according to the relevant reporting guidelines, i.e. CONSORT for randomized controlled trials, TREND for non-randomized trials, and other specialized guidelines as appropriate.

Authors of manuscripts describing the results of clinical trials must adhere to the CONSORT reporting guidelines appropriate to their trial design, available on the CONSORT Statement web site. Before the paper can enter peer review, authors must:

Provide the registry name and number in the methods section of the manuscript
Provide a copy of the trial protocol as approved by the ethics committee and a completed CONSORT checklist as supporting information (which will be published alongside the paper, if accepted). This should be named S1 CONSORT Checklist.
Include the CONSORT flow diagram as the manuscript’s “Figure 1”

Any deviation from the trial protocol must be explained in the paper. Authors must explicitly discuss informed consent in their paper, and we reserve the right to ask for a copy of the patient consent form.

All clinical trials must be registered in one of the publicly-accessible registries approved by the WHO or ICMJE (International Committee of Medical Journal Editors). Authors must provide the trial registration number. Prior disclosure of results on a clinical trial registry site will not affect consideration for publication. We reserve the right to inform authors’ institutions or ethics committees, and to reject the manuscript, if we become aware of unregistered trials. Where trials were not publicly registered before participant recruitment began, authors must:

Register all related clinical trials and confirm they have done so in the Methods section
Explain in the Methods the reason for failing to register before participant recruitment.

Systematic Reviews

The authors should follow the PRISMA statement for thei reviews.

Ethical Responsibilities of Authors

This Journal is committed to upholding the integrity of the scientific record. Authors should refrain from misrepresenting research results which could damage the trust in the Journal, the professionalism of scientific authorship, and ultimately the entire scientific endeavour. Maintaining integrity of the research and its presentation is helped by following the rules of good scientific practice, which include*:

The manuscript should not be submitted to more than one Journal for simultaneous consideration.
The submitted work should be original and should not have been published elsewhere in any form or language (partially or in full), unless the new work concerns an expansion of previous work. (Please provide transparency on the re-use of material to avoid the concerns about text-recycling (‘self-plagiarism’).
A single study should not be split up into several parts to increase the quantity of submissions and submitted to various journals or to one Journal over time (i.e. ‘salami-slicing/publishing’).
Concurrent or secondary publication is sometimes justifiable, provided certain conditions are met. Examples include: translations or a manuscript that is intended for a different group of readers.
Results should be presented clearly, honestly, and without fabrication, falsification or inappropriate data manipulation (including image based manipulation). Authors should adhere to discipline-specific rules for acquiring, selecting and processing data.

No data, text, or theories by others are presented as if they were the author’s own (‘plagiarism’). Proper acknowledgements to other works must be given (this includes material that is closely copied (near verbatim), summarized and/or paraphrased), quotation marks (to indicate words taken from another source) are used for verbatim copying of material, and permissions secured for material that is copyrighted.
Authors should make sure they have permissions for the use of software, questionnaires/(web) surveys and scales in their studies (if appropriate).
Research articles and non-research articles (e.g. Opinion, Review, and Commentary articles) must cite appropriate and relevant literature in support of the claims made. Excessive and inappropriate self-citation or coordinated efforts among several authors to collectively self-cite is strongly discouraged.
Authors should avoid untrue statements about an entity (who can be an individual person or a company) or descriptions of their behavior or actions that could potentially be seen as personal attacks or allegations about that person.
Authors must avoid all statements that can be unlawful, misrepresentative, libelous, plagurous or that would constitute a breach of contract or confidence or commitment to secrecy.
Authors are strongly advised to ensure the author group, the Corresponding Author, and the order of authors are all correct at submission. Adding and/or deleting authors during the revision stages is generally not permitted, but in some cases may be warranted. Reasons for changes in authorship should be explained in detail. Please note that changes to authorship cannot be made after acceptance of a manuscript.

*All of the above are guidelines and authors need to make sure to respect third parties rights such as copyright and/or moral rights.

Upon request authors should be prepared to send relevant documentation or data in order to verify the validity of the results presented. This could be in the form of raw data, samples, records, etc. Sensitive information in the form of confidential or proprietary data is excluded.

If there is suspicion of misbehavior or alleged fraud the Journal and/or Publisher will carry out an investigation following COPE guidelines. If, after investigation, there are valid concerns, the author(s) concerned will be contacted under their given e-mail address and given an opportunity to address the issue. Depending on the situation, this may result in the Journal’s and/or Publisher’s implementation of the following measures, including, but not limited to:

If the manuscript is still under consideration, it may be rejected and returned to the author.
If the article has already been published online, depending on the nature and severity of the infraction:

– an erratum/correction may be placed with the article

– an expression of concern may be placed with the article

– or in severe cases retraction of the article may occur.

The reason will be given in the published erratum/correction, expression of concern or retraction note. Please note that retraction means that the article is maintained on the platform, watermarked “retracted” and the explanation for the retraction is provided in a note linked to the watermarked article.

The author’s institution may be informed
A notice of suspected transgression of ethical standards in the peer review system may be included as part of the author’s and article’s bibliographic record.

To ensure objectivity and transparency in research and to ensure that accepted principles of ethical and professional conduct have been followed, authors should include information regarding sources of funding, potential conflicts of interest (financial or non-financial), informed consent if the research involved human participants, and a statement on welfare of animals if the research involved animals.

Fundamental errors

Authors have an obligation to correct mistakes once they discover a significant error or inaccuracy in their published article. The author(s) is/are requested to contact the Journal and explain in what sense the error is impacting the article. A decision on how to correct the literature will depend on the nature of the error. This may be a correction or retraction. The retraction note should provide transparency which parts of the article are impacted by the error.

Patient Identification and Informed Consent

Informed consent is not needed if the patient cannot be identified from any material in a manuscript. In the absence of informed consent, identifying details, such as patient initials, specific dates, specific geographic exposures, or other identifying features (including body features in figures), should be omitted, but this must not alter the scientific meaning. Important information that is relevant to the scientific meaning should be stated so that the patient cannot be identified, e.g., by stating a season instead of a date or a region instead of a city. If a patient can be identified from the material in a manuscript, all efforts should be made to obtain informed consent to publish from patients or parents/legal guardians of minors. Informed consent requires that the patient have the opportunity to see the manuscript prior to submission. The written consent must state either that the patient has seen the complete manuscript or that the patient declines to do so. Patient consent should be archived with the authors and be available upon request. A statement attesting the receipt and archiving of written patient consent should be included in the published article.

“Patients have a right to privacy that should not be infringed without informed consent. Identifying information, including patients’ names, initials, or hospital numbers, should not be published in written descriptions, photographs, and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Informed consent for this purpose requires that a patient who is identifiable be shown the manuscript to be published. Authors should identify individuals who provide writing assistance and disclose the funding source for this assistance. Identifying details should be omitted if they are not essential. Complete anonymity is difficult to achieve, however, and informed consent should be obtained if there is any doubt. For example, masking the eye region in photographs of patients is inadequate protection of anonymity. If identifying characteristics are altered to protect anonymity, such as in genetic pedigrees, authors should provide assurance that alterations do not distort scientific meaning and editors should so note. The requirement for informed consent should be included in the Journal’s instructions for authors. When informed consent has been obtained it should be indicated in the published article”.

International Committee of Medical Journal Editors (“Uniform Requirements for Manuscripts Submitted to Biomedical Journals”), February 2006

Authorship Principles

Corresponding Author and Group Authorship

The corresponding author will serve on behalf of all co-authors as the primary correspondent with the editorial office during the submission and review process. If the manuscript is accepted, the corresponding author will review an edited typescript and proof and will be identified as the corresponding author in the published article. The Corresponding Author is responsible for the following requirements:

ensuring that all listed authors have approved the manuscript before submission, including the names and order of authors;
managing all communication between the Journal and all co-authors, before and after publication;*
providing transparency on re-use of material and mention any unpublished material (for example manuscripts in press) included in the manuscript in a cover letter to the Editor;
making sure disclosures, declarations and transparency on data statements from all authors are included in the manuscript as appropriate (see above).

The Journal assumes all authors agreed with the content and that all gave explicit consent to submit and that they obtained consent from the responsible authorities at the institute/organization where the work has been carried out, before the work is submitted.

The Journal follows the ICMJE definition of authorship, which indicates that authorship be based on the following 4 criteria:

Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND
Drafting the work or revising it critically for important intellectual content; AND
Final approval of the version to be published; AND
Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Disclosures and declarations

All authors are requested to include information regarding sources of funding, financial or non-financial interests, study-specific approval by the appropriate ethics committee for research involving humans and/or animals, informed consent if the research involved human participants, and a statement on welfare of animals if the research involved animals (as appropriate).

Authors have to declare the contribution statement. An example is here provided:

• Conceptualization: [full name], …; Methodology: [full name], …; Formal analysis and investigation: [full name], …; Writing – original draft preparation: [full name, …]; Writing – review and editing: [full name], …; Funding acquisition: [full name], …; Resources: [full name], …; Supervision: [full name],….

For review articles where discrete statements are less applicable a statement should be included who had the idea for the article, who performed the literature search and data analysis, and who drafted and/or critically revised the work.

Changes to authorship

Authors are strongly advised to ensure the correct author group, the Corresponding Author, and the order of authors at submission. Changes of authorship by adding or deleting authors, and/or changes in Corresponding Author, and/or changes in the sequence of authors are not accepted after acceptance of a manuscript.

Please note that author names will be published exactly as they appear on the accepted submission!

Please make sure that the names of all authors are present and correctly spelled, and that addresses and affiliations are current.

Adding and/or deleting authors at revision stage are generally not permitted, but in some cases it may be warranted. Reasons for these changes in authorship should be explained. Approval of the change during revision is at the discretion of the Editor-in-Chief. Please note that journals may have individual policies on adding and/or deleting authors during revision stage.

Author identification

Authors are recommended to use their ORCID ID when submitting an article for consideration or acquire an ORCID ID via the submission process.

Authorship issues or disputes

In the case of an authorship dispute during peer review or after acceptance and publication, the Journal will not be in a position to investigate or adjudicate. Authors will be asked to resolve the dispute themselves. If they are unable the Journal reserves the right to withdraw a manuscript from the editorial process or in case of a published paper raise the issue with the authors’ institution(s) and abide by its guidelines.

Conflicts of Interest / Competing Interests

Authors are requested to disclose interests that are directly or indirectly related to the work submitted for publication. Interests within the last 3 years of beginning the work (conducting the research and preparing the work for submission) should be reported. Interests outside the 3-year time frame must be disclosed if they could reasonably be perceived as influencing the submitted work. Disclosure of interests provides a complete and transparent process and helps readers form their own judgments of potential bias. This is not meant to imply that a financial relationship with an organization that sponsored the research or compensation received for consultancy work is inappropriate.

Interests that should be considered and disclosed but are not limited to the following:

Funding: Research grants from funding agencies (please give the research funder and the grant number) and/or research support (including salaries, equipment, supplies, reimbursement for attending symposia, and other expenses) by organizations that may gain or lose financially through publication of this manuscript.

Employment: Recent (while engaged in the research project), present or anticipated employment by any organization that may gain or lose financially through publication of this manuscript. This includes multiple affiliations (if applicable).

Financial interests: Stocks or shares in companies (including holdings of spouse and/or children) that may gain or lose financially through publication of this manuscript; consultation fees or other forms of remuneration from organizations that may gain or lose financially; patents or patent applications whose value may be affected by publication of this manuscript.

It is difficult to specify a threshold at which a financial interest becomes significant, any such figure is necessarily arbitrary, so one possible practical guideline is the following: “Any undeclared financial interest that could embarrass the author were it to become publicly known after the work was published.”

Non-financial interests: In addition, authors are requested to disclose interests that go beyond financial interests that could impart bias on the work submitted for publication such as professional interests, personal relationships or personal beliefs (amongst others). Examples include, but are not limited to: position on editorial board, advisory board or board of directors or other type of management relationships; writing and/or consulting for educational purposes; expert witness; mentoring relations; and so forth.

Primary research articles require a disclosure statement. Review articles present an expert synthesis of evidence and may be treated as an authoritative work on a subject. Review articles therefore require a disclosure statement.Other article types such as editorials, book reviews, comments (amongst others) may, dependent on their content, require a disclosure statement. If you are unclear whether your article type requires a disclosure statement, please contact the Editor-in-Chief.

Please note that, in addition to the above requirements, funding information (given that funding is a potential conflict of interest (as mentioned above) needs to be disclosed upon submission of the manuscript in the peer review system. This information will automatically be added to the Record of CrossMark, however it is not added to the manuscript itself. Under ‘summary of requirements’ (see below) funding information should be included in the ‘Declarations’ section.

THE ORCID Initiative

An ORCID (Open Researcher and Contributor) iD is an alphanumeric code to uniquely identify authors.

“ORCID provides a persistent digital identifier (an ORCID iD) that you own and control, and that distinguishes you from every other researcher. You can connect your iD with your professional information — affiliations, grants, publications, peer review, and more. You can use your iD to share your information with other systems, ensuring you get recognition for all your contributions, saving you time and hassle, and reducing the risk of errors.”

The corresponding author should indicate author’s ORCIDs, if available, directly in the template journal that is used for the submission (in the metadata section of the paper).